Investing.com - Financial Markets Worldwide

Meta and Biontech Lead Market Cap Stock Movers on Monday

Published 02/06/2025, 19:04
© Reuters.

Monday’s trading session has showcased notable fluctuations among stocks, particularly within the mega-cap and large-cap sectors. Market participants are witnessing significant movements based on the latest company news and market dynamics. Stocks such as Meta Platforms (NASDAQ:META) and Biontech (BNTX) are experiencing upward momentum, while others like Procter & Gamble (NYSE:PG) are on the decline. Here’s an overview of some of the most impactful stock movers across the market cap spectrum.

Mega-Cap Movers (Market Cap $200B+)

  • Meta Platforms (META); Meta Platforms to fully automate advertising with AI by 2026 - WSJ: +2.73%
  • Avago Technologies (NASDAQ:AVGO): +2.79%
  • Procter & Gamble (PG): -2.13%

Large-Cap Stock Movers (Market Cap $10B-$200B)

  • Biontech (BNTX); Bristol-Myers Squibb (NYSE:BMY) and Biontech enter up to $11.1B Cancer Deal: +20.2%
  • Regencell Bioscience Holdings (RGC): -13.23%
  • Steel Dynamics (NASDAQ:STLD): +9.48%
  • AngloGold Ashanti Ltd (NYSE:AU): +8.48%
  • Nucor (NYSE:NUE): +8.31%
  • Diamond Eagle Acquisition Corp (NASDAQ:DKNG): -7.13%
  • Zscaler Inc (NASDAQ:ZS): +5.78%
  • Newmont Mining (NYSE:NEM): +5.14%
  • First Solar Inc (NASDAQ:FSLR): -5.35%
  • Leidos Holdings (NYSE:LDOS): -5.1%

Mid-Cap Stock Movers (Market Cap $2B-$10B)

  • Blueprint Medicines Corp (NASDAQ:BPMC); JPMorgan downgrades Blueprint Medicines stock after Sanofi (NASDAQ:SNY) acquisition: +25.93%
  • Cleveland Cliffs (NYSE:CLF): +20.44%
  • Tempus AI (TEM); Tempus AI unveils liquid biopsy for cancer treatment monitoring: +17.34%
  • Scnc App In (NASDAQ:SAIC); SAIC shares tumble over 6% as Q1 earnings miss estimates: -14.53%
  • Apellis Pharma (NASDAQ:APLS): +13.56%
  • Pony Ai Inc (PONY); PONY AI Inc. Reaches Strategic Partnership with Xihu Group for Robotaxi Deployment in Shenzhen: -11.73%
  • Hecla Mining Comp (NYSE:HL): +10.21%
  • Novocure Ltd (NASDAQ:NVCR): -11.41%
  • Ascendis Pharma AS (NASDAQ:ASND); FDA prioritizes review of Ascendis Pharma’s growth disorder drug: +8.4%
  • Corcept Therapeutics (NASDAQ:CORT); Relacorilant shows promise for ovarian cancer treatment: -6.3%

Small-Cap Stock Movers (Market Cap $300M-$2B)

  • Vera Therapeutics (VERA); Atacicept trial shows promise in kidney disease treatment: +64.38%
  • Applied Blockchain (APLD); Applied Digital secures $7 billion AI data center deal: +50.0%
  • Kymera Therapeutics Inc (NASDAQ:KYMR); Kymera reports promising Phase 1 results for KT-621: +45.39%
  • Theravance Biopharma Inc (NASDAQ:TBPH): +21.4%
  • Century Aluminum Co (NASDAQ:CENX); U.S. hikes aluminum tariffs; Century Aluminum to expand: +17.79%
  • Olema Pharmaceuticals Inc (OLMA): -16.0%
  • Verastem Inc (NASDAQ:VSTM); Verastem reports promising cancer drug trial results: -17.89%
  • Maze Therapeutics (MAZE): +19.18%
  • Simulations Plus (NASDAQ:SLP): -15.2%
  • Immatics NV (IMTX): +14.1%

For real-time, market-moving news, join Investing Pro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.